Epstein-Barr Virus Seropositivity, Immune Dysregulation, and Mortality in Pediatric Sepsis
Aditya Sriram(University of Pittsburgh), Hyun Jung Park(University of Pittsburgh), Andrew H. Walton(Washington University in St. Louis), Murray M. Pollack(George Washington University Hospital), Kate F. Kernan(Washington University in St. Louis), Rick Harrison, Karen Brengel‐Pesce(bioMérieux (France)), Valérie Cheynet(bioMérieux (France)), Stephanie S. Cabler(Washington University in St. Louis), Zachary Aldewereld(Children's Hospital of Pittsburgh), Scott Canna(Children's Hospital of Philadelphia), Kenneth E. Remy(Washington University in St. Louis), Mark W. Hall(Nationwide Children's Hospital), Yidi Qin(China Agricultural University), Robert A. Berg(University of Pennsylvania), Gregory A. Storch(Washington University in St. Louis), Kit Newth(University of Southern California), Joseph A. Carcillo(University of Pittsburgh)
Cited by 3
Related Papers
Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children
|Pediatric Critical Care Medicine|2020|1.2k
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
|New England Journal of Medicine|2006|902
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
|Critical Care Medicine|2015|858